Cargando…

New therapeutic perspectives – amyloid removal

Detalles Bibliográficos
Autor principal:	Pepys, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642050/ http://dx.doi.org/10.1186/1750-1172-10-S1-I17

Ejemplares similares

Imaging cardiac ATTR amyloid
por: Hawkins, Philip N
Publicado: (2015)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Removing unnecessary obstacles to randomised trials
por: Collins, Rory
Publicado: (2013)

New perspectives on immunological pathways underlying peanut-induced anaphylaxis
por: Jordana, Manel
Publicado: (2011)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

Type 1 diabetes - an auto-inflammatory disease: a new concept, new therapeutical strategies
por: Limbert, Catarina
Publicado: (2012)

The patient’s perspective on precautionary labelling
por: DunnGalvin, Audrey
Publicado: (2011)

EDI200 therapeutic trial
por: Huttner, Kenneth
Publicado: (2012)

Therapeutic education programme in TTR-FAP
por: Théaudin, Marie, et al.
Publicado: (2015)

Migraine and functional connectivity: an innovative pathophysiological perspective.
por: de Tommaso, Marina, et al.
Publicado: (2015)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

Is lack of habituation a biomarker of migraine? A critical perspective
por: Brighina, Filippo, et al.
Publicado: (2015)

A global virus network and a perspective on viral infections in humans
por: Gallo, Robert
Publicado: (2012)

Molecular control of HIV - 1 postintegration latency: implications for therapeutic strategies
por: Van Lint, Carine
Publicado: (2012)

New antiretrovirals
por: Gulick, Roy
Publicado: (2012)

S2. Therapeutic strategies based on overcoming immune resistance mechanisms within the melanoma tumour microenvironment
por: Gajewski, T
Publicado: (2014)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

Diffusion of new antiretroviral drugs in CSF
por: Aweeka, Francesca
Publicado: (2010)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

What is new in the treatment of eosinophilic eosophagitis?
por: Assa'ad, Amal
Publicado: (2011)

New tools to diagnose and follow FAC patients: biomarkers
por: Merlini, Giampaolo
Publicado: (2015)

New medicines to improve control and contribute to the eradication of malaria
por: Wells, Timothy NC
Publicado: (2010)

Retroviral restriction factors: new mechanisms of innate immunity
por: Wolf, Daniel, et al.
Publicado: (2009)

Finding new immune regulatory genes by ENU mutagenesis
por: Enders, Anselm, et al.
Publicado: (2012)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

Use of new technologies to detect and understand HIV drug resistance
por: Kozal, Michael J
Publicado: (2010)

PReS13-SPK-1240: New aspects on APS pathogenesis
por: Meroni, PL
Publicado: (2013)

Impact of a new European regulations on functional food market – an overview
por: Lovik, Martinus
Publicado: (2011)

PReS13-SPK-1034: looking for new monogenic forms of lupus
por: Crow, Y
Publicado: (2013)

Food allergen protein families and their structural characteristics: new data from Europrevail
por: Hoffmann-Sommergruber, Karin
Publicado: (2011)

PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA
por: Livermore, P
Publicado: (2013)

PReS13-SPK-1137: New developments in our care & understanding of JIA
por: Beresford, MW
Publicado: (2013)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome
por: Van den Steen, Philippe E, et al.
Publicado: (2010)

PReS13-SPK-1587: New biologic targets for the future and basic science behind them
por: Prakken, B
Publicado: (2013)

PReS13-SPK-1408: New EU scientific guidelines for JIA, SLE and GIOP from the European Medicines Agency
por: Vesely, R
Publicado: (2013)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_92oa1esuqgn66c5be2rnl1d3h2